Articles with public access mandates - Ritwik BuraiLearn more
Not available anywhere: 2
Elucidating the role of site-specific nitration of α-synuclein in the pathogenesis of Parkinson’s disease via protein semisynthesis and mutagenesis
R Burai, N Ait-Bouziad, A Chiki, HA Lashuel
Journal of the American Chemical Society 137 (15), 5041-5052, 2015
Mandates: Swiss National Science Foundation, European Commission
A crystalline ready-to-use form of cyclopentadiene
F Krupp, S He, W Frey, C Richert
Synlett 29 (13), 1707-1710, 2018
Mandates: German Research Foundation
Available somewhere: 13
In vivo effects of a GPR30 antagonist
MK Dennis, R Burai, C Ramesh, WK Petrie, SN Alcon, TK Nayak, ...
Nature chemical biology 5 (6), 421-427, 2009
Mandates: US National Institutes of Health
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
MK Dennis, AS Field, R Burai, C Ramesh, WK Petrie, CG Bologa, ...
The Journal of steroid biochemistry and molecular biology 127 (3-5), 358-366, 2011
Mandates: US National Institutes of Health
Activation of the STING-dependent type I interferon response reduces microglial reactivity and neuroinflammation
V Mathur, R Burai, RT Vest, LN Bonanno, B Lehallier, ME Zardeneta, ...
Neuron 96 (6), 1290-1302. e6, 2017
Mandates: US National Institutes of Health, US Department of Education, US Department …
Mutant Exon1 huntingtin aggregation is regulated by T3 phosphorylation‐induced structural changes and crosstalk between T3 phosphorylation and acetylation at K6
A Chiki, SM DeGuire, FS Ruggeri, D Sanfelice, A Ansaloni, ZM Wang, ...
Angewandte Chemie International Edition 56 (19), 5202-5207, 2017
Mandates: Swiss National Science Foundation, UK Medical Research Council
Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30
C Ramesh, TK Nayak, R Burai, MK Dennis, HJ Hathaway, LA Sklar, ...
Journal of medicinal chemistry 53 (3), 1004-1014, 2010
Mandates: US National Institutes of Health
Highly efficient synthesis and characterization of the GPR30-selective agonist G-1 and related tetrahydroquinoline analogs
R Burai, C Ramesh, M Shorty, R Curpan, C Bologa, LA Sklar, T Oprea, ...
Organic & biomolecular chemistry 8 (9), 2252-2259, 2010
Mandates: US National Institutes of Health
Influence of Charge on Cell Permeability and Tumor Imaging of GPR30-Targeted 111In-Labeled Nonsteroidal Imaging Agents
TK Nayak, MK Dennis, C Ramesh, R Burai, RW Atcher, LA Sklar, ...
ACS chemical biology 5 (7), 681-690, 2010
Mandates: US National Institutes of Health
Synthesis and characterization of tricarbonyl-Re/Tc (I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30
R Burai, C Ramesh, TK Nayak, MK Dennis, BK Bryant, ER Prossnitz, ...
Public Library of Science 7 (10), e46861, 2012
Mandates: US National Institutes of Health
Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
HA Lashuel, AL Mahul-Mellier, S Novello, RN Hegde, Y Jasiqi, MF Altay, ...
npj Parkinson's Disease 8 (1), 136, 2022
Mandates: Michael J Fox Foundation
Comparative analysis of total alpha-synuclein (αSYN) immunoassays reveals that they do not capture the diversity of modified αSYN proteoforms
L Petricca, N Chiki, L Hanna-El-Daher, L Aeschbach, R Burai, E Stoops, ...
Journal of Parkinson's Disease 12 (5), 1449-1462, 2022
Mandates: Michael J Fox Foundation
A New Caged‐Glutamine Derivative as a Tool To Control the Assembly of Glutamine‐Containing Amyloidogenic Peptides
L Awad, N Jejelava, R Burai, HA Lashuel
ChemBioChem 17 (24), 2353-2360, 2016
Mandates: Swiss National Science Foundation
Neighbouring modifications interfere with the detection of phosphorylated alpha-synuclein at Serine 129: Revisiting the specificity of pS129 antibodies
HA Lashuel, AL Mahul-Mellier, S Novello, RN Hegde, Y Jasiqi, MF Altay, ...
bioRxiv, 2022.03. 30.486322, 2022
Mandates: Michael J Fox Foundation
Synthesis and Characterization of Tricarbonyl-Re
R Burai, C Ramesh, TK Nayak, MK Dennis, BK Bryant
Tc (I) Chelate Probes Targeting the G, 2012
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program